Imai, K.; Takai, K.; Miwa, T.; Taguchi, D.; Hanai, T.; Suetsugu, A.; Shiraki, M.; Shimizu, M.
Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers 2019, 11, 1206.
https://doi.org/10.3390/cancers11081206
AMA Style
Imai K, Takai K, Miwa T, Taguchi D, Hanai T, Suetsugu A, Shiraki M, Shimizu M.
Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers. 2019; 11(8):1206.
https://doi.org/10.3390/cancers11081206
Chicago/Turabian Style
Imai, Kenji, Koji Takai, Takao Miwa, Daisuke Taguchi, Tatsunori Hanai, Atsushi Suetsugu, Makoto Shiraki, and Masahito Shimizu.
2019. "Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib" Cancers 11, no. 8: 1206.
https://doi.org/10.3390/cancers11081206
APA Style
Imai, K., Takai, K., Miwa, T., Taguchi, D., Hanai, T., Suetsugu, A., Shiraki, M., & Shimizu, M.
(2019). Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers, 11(8), 1206.
https://doi.org/10.3390/cancers11081206